MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 263 filers reported holding MYRIAD GENETICS INC in Q1 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $812,000 | -58.1% | 29,222 | -49.9% | 0.84% | -48.6% |
| Q1 2019 | $1,936,000 | +26.2% | 58,302 | +10.4% | 1.63% | +16.2% |
| Q4 2018 | $1,534,000 | -14.4% | 52,791 | +35.5% | 1.40% | +0.6% |
| Q3 2018 | $1,793,000 | -15.0% | 38,972 | -31.0% | 1.40% | -13.2% |
| Q2 2018 | $2,110,000 | +56.8% | 56,472 | +24.0% | 1.61% | +146.9% |
| Q1 2018 | $1,346,000 | +23.1% | 45,544 | +43.0% | 0.65% | -37.9% |
| Q4 2017 | $1,093,000 | -7.7% | 31,838 | -2.7% | 1.05% | -5.6% |
| Q3 2017 | $1,184,000 | -41.1% | 32,738 | -57.9% | 1.11% | -41.6% |
| Q2 2017 | $2,011,000 | +83.5% | 77,841 | +151.4% | 1.90% | +57.3% |
| Q1 2015 | $1,096,000 | – | 30,964 | – | 1.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |